INTRODUCTION
Nontuberculous mycobacterium (NTM) is a ubiquitous environmental organism that is progressively recognized as a human pathogen. It is unusual for it to cause a true infection, but it can be an important cause of cutaneous infections especially in immunocompromised patients and after invasive procedures such as acupuncture or minor surgery.
Mycobacterium massiliense was first described by Adé-kambi et al. 1 in 2004, and it was firstly isolated from the sputum of a patient with pneumonia. This new species is closely related to the M. abscessus/chelonae group. However, M. massiliense has not been completely understood, and it has been suggested that this species may be different from other mycobacterial infections in its therapeutic response to antimicrobial agents 2 .
CASE REPORT
In February 2011, a 45-year-old male visited our hospital with a painful nodule on his left sole that had appeared four weeks ago. Before visiting our outpatient clinic, he had undergone acupuncture on his back and both extremities including the soles and palms to alleviate chronic back pain. The skin lesion on his left sole developed after a few weeks of receiving acupuncture. On physical examination, the patient showed an erythematous subcutaneous nodule with local tenderness and heat on the sole of his left foot (Fig. 1 ). There was no discharge or fluctuation. No systemic symptoms including fever were detected. Histological examination of a biopsy obtained from the lesion on his sole showed granulomatous inflammation with neutrophilic microabscesses in the dermis and subcutaneous fat tissue. No special staining was performed ( (Fig. 3 ). For identification of the mycobacterium species, polymerase chain reaction-hybridization (REBA Myco-ID Ⓡ , M&D Inc., Wonju, Korea) was performed. We used a molecular diagnostic kit designed to identify 19 species of NTM by binding the amplifying rpo B gene product to a species-specific probe. Then the culture was identified as M. massiliense (Fig. 4) . Susceptibility testing for antibiotics was done using the broth microdilution method according to the criteria of the Clinical and Laboratory Standards Institute. The isolate was susceptible to clarithromycin (minimum inhibitory concentration≤0.5μg/ml) and it showed intermediate susceptibility to amikacin and cefoxitin. However, the isolate was resistant to ciprofloxacin and doxycycline. Because we at first considered his cutaneous lesion to be an abscess or inflammation due to a ruptured epidermal cyst, he received empirical antibiotic treatment with cefadroxil for 2 weeks. And then, based on the susceptibility results, we treated the patient with clarithromycin 100 mg a day for 4 months, and he showed improvement of both his subjective symptoms and his cutaneous lesion.
DISCUSSION
In recent years, nonmycobacterial infections have emerged as an important issue. Along with the increase in the number of people with immunosuppressive states over the past few decades, the incidence of nonmycobacterial infections has increased worldwide. Also, the occurrence of nonmycobacterial infections is usually related to surgical procedures, injections or minor trauma. Acupuncture is widely performed in Asia, especially as these kinds of infections are usually epidemic in this region. massiliense infection are treated with combination therapy including therapy containing clarithromycin 3, 4 . Unlike previous studies, we treated the patient with single-drug therapy consisting of clarithromycin, and at present, he is showing good recovery. This is the third report of a localized skin infection of M. massiliense in Korea (Table 1) 4,5
. Also, it is relatively rare for NTM infections to occur on the sole of the feet. M. massiliense would seem to have different response patterns to antibiotic treatment distinct from other NTM species. Thus, further study is required to verify the clinical features and treatment options for M. massiliense infections.
